234 related articles for article (PubMed ID: 8790197)
1. Comparison of fluorine-18-FDG PET and technetium-99m-MIBI SPECT in evaluation of musculoskeletal sarcomas.
Garcia R; Kim EE; Wong FC; Korkmaz M; Wong WH; Yang DJ; Podoloff DA
J Nucl Med; 1996 Sep; 37(9):1476-9. PubMed ID: 8790197
[TBL] [Abstract][Full Text] [Related]
2. Tc-99m MIBI scintigraphy in patients with lung cancer. Comparison with CT and fluorine-18 FDG PET imaging.
Wang H; Maurea S; Mainolfi C; Fiore F; Gravina A; Panico MR; Bazzicalupo L; Salvatore M
Clin Nucl Med; 1997 Apr; 22(4):243-9. PubMed ID: 9099482
[TBL] [Abstract][Full Text] [Related]
3. Detection of recurrent or persistent nasopharyngeal carcinomas after radiotherapy with technetium-99m methoxyisobutylisonitrile single photon emission computed tomography and computed tomography: comparison with 18-fluoro-2-deoxyglucose positron emission tomography.
Kao CH; Shiau YC; Shen YY; Yen RF
Cancer; 2002 Apr; 94(7):1981-6. PubMed ID: 11932900
[TBL] [Abstract][Full Text] [Related]
4. Comparison of fluorine-18-fluorodeoxyglucose and carbon-11-methionine PET in detection of malignant tumors.
Inoue T; Kim EE; Wong FC; Yang DJ; Bassa P; Wong WH; Korkmaz M; Tansey W; Hicks K; Podoloff DA
J Nucl Med; 1996 Sep; 37(9):1472-6. PubMed ID: 8790196
[TBL] [Abstract][Full Text] [Related]
5. Rest distribution of 99mTc-MIBI in patients with coronary artery disease assessed by SPECT: comparison with the distribution of [18F]FDG assessed by PET.
Gang H; Lucignani G; Landoni C; Galli L; Vanoli G; Rossetti C; Paganelli G; Fazio F
J Nucl Biol Med (1991); 1994 Dec; 38(4):540-4. PubMed ID: 7786915
[TBL] [Abstract][Full Text] [Related]
6. Pre- and post-therapy thallium-201 and technetium-99m-sestamibi SPECT in nasopharyngeal carcinoma.
Kostakoglu L; Uysal U; Ozyar E; Elahi N; Hayran M; Uzal D; Demirkazik FB; Kars A; Uğur O; Atahan L; Bekdik CF
J Nucl Med; 1996 Dec; 37(12):1956-62. PubMed ID: 8970513
[TBL] [Abstract][Full Text] [Related]
7. F-18-2-fluoro-2-deoxyglucose positron emission tomography compared to technetium-99m hexakis-2-methoxyisobutyl isonitrile single photon emission chest tomography in the diagnosis of indeterminate lung lesions.
Santini M; Fiorelli A; Vicidomini G; Laperuta P; Busiello L; Rambaldi PF; Mansi L; Rotondo A
Respiration; 2010; 80(6):524-33. PubMed ID: 20881375
[TBL] [Abstract][Full Text] [Related]
8. Dual-time point 18FDG-PET/CT imaging may be useful in assessing local recurrent disease in high grade bone and soft tissue sarcoma.
Dancheva Z; Bochev P; Chaushev B; Yordanova T; Klisarova A
Nucl Med Rev Cent East Eur; 2016; 19(1):22-7. PubMed ID: 26841376
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis of recurrent brain tumor: value of 201Tl SPECT vs 18F-fluorodeoxyglucose PET.
Kahn D; Follett KA; Bushnell DL; Nathan MA; Piper JG; Madsen M; Kirchner PT
AJR Am J Roentgenol; 1994 Dec; 163(6):1459-65. PubMed ID: 7992747
[TBL] [Abstract][Full Text] [Related]
10. Detecting recurrent or residual lung cancer with FDG-PET.
Inoue T; Kim EE; Komaki R; Wong FC; Bassa P; Wong WH; Yang DJ; Endo K; Podoloff DA
J Nucl Med; 1995 May; 36(5):788-93. PubMed ID: 7738649
[TBL] [Abstract][Full Text] [Related]
11. Comparison of technetium-99m-MIBI and technetium-99m-tetrofosmin uptake by musculoskeletal sarcomas.
Söderlund V; Jonsson C; Bauer HC; Brosjö O; Jacobsson H
J Nucl Med; 1997 May; 38(5):682-6. PubMed ID: 9170427
[TBL] [Abstract][Full Text] [Related]
12. Comparison of fluorine-18 fluorodeoxyglucose positron emission tomography and technetium-99m methoxyisobutylisonitrile scintimammography in the detection of breast tumours.
Palmedo H; Bender H; Grünwald F; Mallmann P; Zamora P; Krebs D; Biersack HJ
Eur J Nucl Med; 1997 Sep; 24(9):1138-45. PubMed ID: 9283107
[TBL] [Abstract][Full Text] [Related]
13. Monitoring of neoadjuvant therapy response of soft-tissue and musculoskeletal sarcoma using fluorine-18-FDG PET.
Jones DN; McCowage GB; Sostman HD; Brizel DM; Layfield L; Charles HC; Dewhirst MW; Prescott DM; Friedman HS; Harrelson JM; Scully SP; Coleman RE
J Nucl Med; 1996 Sep; 37(9):1438-44. PubMed ID: 8790188
[TBL] [Abstract][Full Text] [Related]
14. [Comparison of diagnostic accuracy of (18)F-FDG PET, (123)I-IMT- and (99m)Tc-MIBI SPECT: evaluation of tumour progression in irradiated low grade astrocytomas].
Henze M; Ozdemir-Sahin N; Hipp P; Mier W; Eisenhut M; Debus J; Haberkorn U
Nuklearmedizin; 2006; 45(1):49-56. PubMed ID: 16493514
[TBL] [Abstract][Full Text] [Related]
15. Significance of defect severity in technetium-99m-MIBI SPECT at rest to assess myocardial viability: comparison with fluorine-18-FDG PET.
Altehoefer C; vom Dahl J; Biedermann M; Uebis R; Beilin I; Sheehan F; Hanrath P; Buell U
J Nucl Med; 1994 Apr; 35(4):569-74. PubMed ID: 8151377
[TBL] [Abstract][Full Text] [Related]
16. PET and SPECT for detection of tumor progression in irradiated low-grade astrocytoma: a receiver-operating-characteristic analysis.
Henze M; Mohammed A; Schlemmer HP; Herfarth KK; Hoffner S; Haufe S; Mier W; Eisenhut M; Debus J; Haberkorn U
J Nucl Med; 2004 Apr; 45(4):579-86. PubMed ID: 15073253
[TBL] [Abstract][Full Text] [Related]
17. Rest myocardial perfusion/metabolism imaging using simultaneous dual-isotope acquisition SPECT with technetium-99m-MIBI/fluorine-18-FDG.
Delbeke D; Videlefsky S; Patton JA; Campbell MG; Martin WH; Ohana I; Sandler MP
J Nucl Med; 1995 Nov; 36(11):2110-9. PubMed ID: 7472607
[TBL] [Abstract][Full Text] [Related]
18. 99mTc-MIBI scintigraphy in musculoskeletal tumors.
Pinkas L; Robinson D; Halperin N; Mindlin L; Cohenpour M; Baumer M; Home T
J Nucl Med; 2001 Jan; 42(1):33-7. PubMed ID: 11197977
[TBL] [Abstract][Full Text] [Related]
19. Technetium-99m-MIBI versus fluorine-18-FDG in diffuse multiple myeloma.
el-Shirbiny AM; Yeung H; Imbriaco M; Michaeli J; Macapinlac H; Larson SM
J Nucl Med; 1997 Aug; 38(8):1208-10. PubMed ID: 9255151
[TBL] [Abstract][Full Text] [Related]
20. Recurrent postoperative parathyroid carcinoma: FDG-PET and sestamibi-SPECT findings.
Neumann DR; Esselstyn CB; Kim EY
J Nucl Med; 1996 Dec; 37(12):2000-1. PubMed ID: 8970522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
